Hikma Pharmaceutical | HIK - Ricavi Di Vendita

Prezzo Delle Azioni
1,429.50
Cambio Giornaliero
18.50 1.31%
Mensile
11.20%
Annuale
-28.67%
Q2 Previsione
1,384.20




I Saldi Cambiamento Data
Almirall EUR 547.63M 12.83M 2025-12
argenx SE USD 1.12B 132.91M 2025-12
AstraZeneca USD 15.29B 213M 2026-03
Autolus Therapeutics Ltd USD 24.29M 1.68M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
Fresenius EUR 5.88B 400M 2025-12
Galapagos EUR 900.82M 835.52M 2025-12
Genmab DKK 1.06B 36M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
GRIFOLS EUR 1.98B 110M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.25B 70M 2025-12
Orion EUR 417.7M 277.6M 2026-03
Recordati EUR 662M 37.65M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12